Pathology as Primary Care
October 17, 2025
Why the "quiet backbone of medicine" is so much more than a medical specialty
5 min read

False
Discover the voices driving change and progress in pathology and laboratory medicine. From legacy figures to today’s leading professionals, explore stories, interviews, and community highlights that inspire and inform.
A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
Find out moreSenior Member and Professor of the Department of Pathology and Machine Learning, Scientific Director of Analytic Microscopy Core, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA
View ProfileA new study reveals just how widespread burnout is among laboratory professionals – and what leaders can do to fix it
Your hub for career growth and professional resources
Jul 31, 2025
By Kathryn Wighton
Explore how forensic pathologists support public health, advance research, and guide families through medicolegal death investigations
1 min read
The latest events and developments shaping the field.
12/9/2024
Join expert panelists as we dive into results of a recent Owkin survey aimed at taking the temperature of pathologists and oncologists on the state of the field of pathology in the US, UK and France.
12/10/2024
Evaluation of the Oncomine Comprehensive Assay Plus for comprehensive genomic profiling including homologous recombination deficiency assessment.
12/9/2024
Join expert panelists as we dive into results of a recent Owkin survey aimed at taking the temperature of pathologists and oncologists on the state of the field of pathology in the US, UK and France.
11/26/2024
The MiSeq™ i100 Series is the latest bench top sequencer from Illumina. It delivers breakthrough simplicity, our fastest run times yet, comprehensive analysis, and significant sustainability advancements.
10/23/2025
Rapid comprehensive genomic profiling (CGP) is crucial for gaining important insights when timely results matter.
11/6/2025
Join us for an illuminating webinar titled "Advancing biomarker detection in lymphoid malignancies: Insights from leading scientists," where we bring together two of the foremost authorities in the field of haemato-oncology.
11/12/2025
Pathology is changing. And not just a little—it’s undergoing a transformation that will define the future of healthcare.
All the latest across pathology.
Oct 14, 2025
In conversation with Sebastian Dintner, Head of Molecular Pathology at the Institute of Pathology and Molecular Diagnostics, University Hospital Augsburg, Germany, on his experience with the Oncomine Comprehensive Assay on the Genexus System
3 min read
Oct 14, 2025
Next-generation sequencing test accelerates precision oncology, enabling rapid tumor profiling, streamlined workflows, and supports timely treatment decisions
6 min read
Oct 13, 2025
CAP’s latest joint statement reignites debate over recruitment pressures, transparency, and the future of subspecialty training
3 min read
Oct 13, 2025
By Kathryn Wighton
Researchers found no progression to neoplasia among gastric intestinal metaplasia subtypes, while confirming strong associations with Helicobacter pylori infection.
2 min read
Oct 10, 2025
David Gaze, Senior Lecturer in Chemical Pathology, Director of Employability in the School of Life Science, and Course Leader for MSc Biomedical Science at the University of Westminster, discusses the challenges and rewards of teaching
8 min read
Oct 10, 2025
By Kathryn Wighton
Researchers compared MIB1 and SP6 antibodies for Ki-67 assessment in breast carcinoma.
1 min read
Oct 10, 2025
New guidelines combine hematoxylin and eosin and CD3 staining to improve diagnostic accuracy and reproducibility worldwide
2 min read
Oct 09, 2025
By Jessica Allerton
The discovery of millions of Arab-specific variants shows why inclusive genomics is essential for equity in diagnosis and precision medicine
4 min read
Oct 09, 2025
Findings link disrupted nucleotide metabolism to mtDNA leakage, immune activation, and age-related inflammation
2 min read
Oct 08, 2025
Multiparameter flow cytometry enables measurable residual disease testing and prognosis in patients with multiple myeloma
2 min read
False